Novartis AG Total Liabilities 2010-2024 | NVS

Novartis AG total liabilities for the quarter ending December 31, 2024 were $58.120B, a 9.26% increase year-over-year.

  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
  • Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.

Novartis AG Total Liabilities 2010-2024 | NVS

  • Novartis AG total liabilities for 2024 were $58.12B, a 9.26% increase from 2023.
  • Novartis AG total liabilities for 2023 were $53.195B, a 8.33% decline from 2022.
  • Novartis AG total liabilities for 2022 were $58.03B, a 9.29% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B